ENTRY       D04121                      Drug
NAME        Exenatide (JAN/USAN/INN);
            Byetta (TN)
PRODUCT     BYDUREON BCISE (AstraZeneca Pharmaceuticals LP)
            BYETTA (AstraZeneca Pharmaceuticals LP)
FORMULA     C184H282N50O60S
EXACT_MASS  4184.0273
MOL_WEIGHT  4186.5719
SEQUENCE    His Gly Glu Gly Thr Phe Thr Ser Asp Leu Ser Lys Gln Met Glu Glu
            Glu Ala Val Arg Leu Phe Ile Glu Trp Leu Lys Asn Gly Gly Pro Ser
            Ser Gly Ala Pro Pro Pro Ser
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01493  GLP-1 receptor agonist
REMARK      Same as: C15894
            Therapeutic category: 2499
            ATC code: A10BJ01
            Product: D04121<JP/US>
EFFICACY    Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     GLP-1 [CPD:C16048] analog
TARGET      GLP1R [HSA:2740] [KO:K04581]
  PATHWAY   hsa04080(2740)  Neuroactive ligand-receptor interaction
            hsa04911(2740)  Insulin secretion
INTERACTION  
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BJ Glucagon-like peptide-1 (GLP-1) analogues
                 A10BJ01 Exenatide
                  D04121  Exenatide (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               GLP-1 Receptor Agonist
                Exenatide
                 D04121  Exenatide (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D04121  Exenatide (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01493  GLP-1 receptor agonist
                D04121  Exenatide
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01493  GLP-1 receptor agonist
               D04121  Exenatide
              DG02044  Hypoglycemic agent
               D04121  Exenatide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                GLP1R
                 D04121  Exenatide (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04121
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D04121
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D04121
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04121
DBLINKS     CAS: 141758-74-9
            PubChem: 47206069
            ChEBI: 64073
            NIKKAJI: J1.038.138J
///
